About
Ditch Labs is a clinical-stage digital health and life sciences company based in Montreal, Canada, founded in 2019. The company specializes in innovative solutions for nicotine addiction treatment and smoking cessation. Its flagship product, the DitchPen®, is a prescription-based medical inhaler that delivers nicotine replacement therapy through a patented dual aerosolization system. This system allows for precise control of nicotine delivery, enabling users to gradually reduce their intake over a 12-week period. In addition to the DitchPen®, Ditch Labs offers a companion digital therapeutic app that tracks nicotine consumption and provides personalized feedback. The app features over 150 educational modules to support users in their cessation journey, addressing psychological triggers and offering comprehensive support. Ditch Labs aims to empower smokers worldwide to overcome nicotine addiction and improve public health, while also exploring broader applications of its vaporization technology for other medical uses. The company employs around 10 people and emphasizes innovation by combining medical devices with data-driven solutions.
Technologies
Keywords
Company Information
-
Employees 6
-
Founded 2020
-
Annual Revenue $1000000
-
Total Funding $2471218
Location
Pendyris Street, Cardiff, Wales, United Kingdom, CF11 6RJ
